Tuberculosis is a chronic wasting infectious disease caused by Mycobacterium tuberculosis. The drugs used to treat this disease are anti-tuberculosis drugs.

Market Analysis and Insights: Global Anti-Tuberculosis Drug Market
The global Anti-Tuberculosis Drug market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Anti-Tuberculosis Drug Scope and Market Size
The global Anti-Tuberculosis Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Tuberculosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
First-Line Anti-Tuberculosis Drugs
Second-Line Anti-Tuberculosis Drugs

Segment by Application
Hospital
Clinic
Others

The Anti-Tuberculosis Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Anti-Tuberculosis Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Lupin
Otsuka
Sanofi
Prizer
Abbott
NOVARTIS